About this trial
The investigators propose a parallel group randomized clinical trial of intrapartum nipple stimulation versus exogenous oxytocin infusion for nulliparous women undergoing induction of labor near term. The central hypothesis is that intrapartum nipple stimulation to induce labor increases spontaneous vaginal delivery, improves patient-centered outcomes such as childbirth satisfaction, labor agentry, and pain scores, and reduces adverse neonatal and maternal outcomes in nulliparous women. The investigators will pursue the following specific aims: 1) Assess the effectiveness of intrapartum nipple stimulation on the rate of spontaneous vaginal delivery in nulliparous women, 2) Breastfeeding as the sole source of nutrition at time of maternal hospital discharge (Primary Aims); 3) Maximal percent newborn weight loss during the birth hospitalization within 72 hours of life, 4) Determine the effect of intrapartum nipple stimulation on the rate of adverse maternal and neonatal outcomes, 5) Determine the impact of intrapartum nipple stimulation on patient-centered outcomes and 6) In a sub-cohort of women who are enrolled in the trial, investigators will measure the change in oxytocin concentration from baseline to time at which patient achieves a regular contraction pattern.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Nulliparous
Gestational age 36 0/7 weeks and greater at enrollment
Singleton gestation
Planned to undergo initiation of exogenous oxytocin infusion by their maternity care provider
Disqualifiers
Unable to understand English or Spanish
Prior use of exogenous oxytocin or attempt at nipple stimulation during the current pregnancy
Presence of tachysystole (defined as more than 5 contractions in 10 minutes averaged over 30 minutes), recurrent variable or late fetal decelerations, and bradycardia in the prior 30 minutes before enrollment
Non-vertex presenting fetus at time of enrollment
Trial design
Parallel
Treatments tested in this trial
Electric breast pump
DeviceParticipants randomized to the intrapartum nipple stimulation will use electric breast pump or nipple stimulate by hand (if preferred) (intervention) to induce labor for at least 2 hours
Exogenous oxytocin intravenous infusion without nipple stimulation.
DrugParticipants randomized to the standard care arm will use exogenous oxytocin intravenous infusion to induce labor as current standard of care
Treatment groups
Trial outcomes
Primary outcomes
Spontaneous vaginal delivery
Spontaneous vaginal delivery will be defined as delivery that occurs without the use of forceps, vacuum, or cesarean
Breastfeeding as the sole source of nutrition (BSSN)
Number of participants using breastfeeding as the sole source of nutrition (BSSN) at time of maternal discharge or 72 hours of life (whichever is sooner)
Secondary outcomes
Operative vaginal delivery
Delivery with the assistance of forceps or vacuum, and indication
Cesarean delivery
Delivery by cesarean section
Labor induction duration
Time interval from randomization to delivery
Number of Participants with Postpartum hemorrhage
Cumulative blood loss of ≥1,000 mL within 24 hours after the birth process
Other outcomes
Subject-reported pain during childbirth
Visual analog scale, scored with Likert scale from 0 (no pain) to 10 (worst pain)
Subject-reported satisfaction during labor and childbirth
Birth Satisfaction Scale-Revised (BSS-R) is a 10-item self-report valid and reliable measure (scores range from 0 to 40, 0 being the least satisfaction and 40 being the most satisfaction)
Subject-reported feelings of control during labor and childbirth
Labor Agentry Scale is a 29-item survey designed to assess expectations and experiences of personal control during childbirth (scores range from 29 to 203, with higher scores indicating greater perceived control during childbirth)
Subject-reported depression score
Edinburgh Postnatal Depression Scale is a 10-item self report scored from 0 to 30; score \>10 warrants additional clinical assessment for depression
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yale University
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator